BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/29/2021 2:12:02 AM | Browse: 332 | Download: 629
 |
Received |
|
2021-01-25 21:59 |
|
Peer-Review Started |
|
2021-01-25 22:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-27 22:38 |
|
Revised |
|
2021-03-06 00:56 |
|
Second Decision |
|
2021-04-12 12:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-12 18:44 |
|
Articles in Press |
|
2021-04-12 18:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-27 01:36 |
|
Publish the Manuscript Online |
|
2021-04-29 02:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Shengir, Mohamed Elgara and Giada Sebastiani |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Junior 1 and 2 Salary Award from Fonds de la Recherche en Santé du Québec |
27127 |
| Junior 1 and 2 Salary Award from Fonds de la Recherche en Santé du Québec |
267806 |
| Research Salary from the Department of Medicine of McGill University |
|
| Pfizer via Unrestricted Educational Grant |
|
|
| Corresponding Author |
Giada Sebastiani, MD, Associate Professor, Department of Medicine, McGill University Health Center, 1001 Blvd. Decarie, Montreal H4A3J1, Quebec, Canada. giada.sebastiani@mcgill.ca |
| Key Words |
Chronic hepatitis C; Sustained virologic response; Hepatic steatosis; Diabetes mellitus; Cardiovascular disease |
| Core Tip |
The implementation of direct acting antiviral drugs has dramatically changed the landscape of hepatitis C virus (HCV) treatment, with over 95% of patients achieving sustained virologic response (SVR). Although consistent evidence demonstrated better outcomes for both hepatic and extrahepatic complications after viral clearance, data on cardiometabolic manifestation showed inconsistent results. In this review, we are shading light on the latest findings about cardiometabolic extrahepatic manifestations post-SVR. These updates may guide clinicians engaged in HCV care to integrate in their management post-viral eradication risks and subsequent long-term care. |
| Publish Date |
2021-04-29 02:12 |
| Citation |
Shengir M, Elgara M, Sebastiani G. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World J Gastroenterol 2021; 27(17): 1959-1972 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i17/1959.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i17.1959 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
